Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Visual attention to faces in children with autism spectrum disorder: are there sex differences?

Harrop C, Jones D, Zheng S, Nowell S, Schultz R, Parish-Morris J.

Mol Autism. 2019 Jun 28;10:28. doi: 10.1186/s13229-019-0276-2. eCollection 2019.

2.

Efficacy Study of a Social Communication and Self-Regulation Intervention for School-Age Children With Autism Spectrum Disorder: A Randomized Controlled Trial.

Nowell SW, Watson LR, Boyd B, Klinger LG.

Lang Speech Hear Serv Sch. 2019 Jul 12;50(3):416-433. doi: 10.1044/2019_LSHSS-18-0093. Epub 2019 Jul 9.

PMID:
31287766
3.

INCREASED MORTALITY IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM: DOES SURGERY MAKE A DIFFERENCE?

Collier A, Ghosh S, Nowell S, Clark D.

Endocr Pract. 2019 Apr;25(4):335-339. doi: 10.4158/EP-2018-0407.

PMID:
30995426
4.

Survival and new-onset morbidity after critical care admission for acute pancreatitis in Scotland: a national electronic healthcare record linkage cohort study.

Ventre C, Nowell S, Graham C, Kidd D, Skouras C, Mole DJ.

BMJ Open. 2018 Dec 14;8(12):e023853. doi: 10.1136/bmjopen-2018-023853.

5.

Sex differences in social attention in autism spectrum disorder.

Harrop C, Jones D, Zheng S, Nowell SW, Boyd BA, Sasson N.

Autism Res. 2018 Sep;11(9):1264-1275. doi: 10.1002/aur.1997. Epub 2018 Sep 11.

PMID:
30403327
6.

Perinatal risks in female cancer survivors: A population-based analysis.

van der Kooi ALF, Brewster DH, Wood R, Nowell S, Fischbacher C, van den Heuvel-Eibrink MM, Laven JSE, Wallace WHB, Anderson RA.

PLoS One. 2018 Aug 23;13(8):e0202805. doi: 10.1371/journal.pone.0202805. eCollection 2018.

7.

The impact of cancer on subsequent chance of pregnancy: a population-based analysis.

Anderson RA, Brewster DH, Wood R, Nowell S, Fischbacher C, Kelsey TW, Wallace WHB.

Hum Reprod. 2018 Jul 1;33(7):1281-1290. doi: 10.1093/humrep/dey216.

8.

Circumscribed Interests and Attention in Autism: The Role of Biological Sex.

Harrop C, Jones D, Zheng S, Nowell S, Boyd BA, Sasson N.

J Autism Dev Disord. 2018 Oct;48(10):3449-3459. doi: 10.1007/s10803-018-3612-z.

PMID:
29777472
9.

An Initial Psychometric Evaluation of the Joint Attention Protocol.

Nowell SW, Watson LR, Faldowski RA, Baranek GT.

J Autism Dev Disord. 2018 Jun;48(6):1932-1944. doi: 10.1007/s10803-017-3458-9.

10.

Cascading effects of attention disengagement and sensory seeking on social symptoms in a community sample of infants at-risk for a future diagnosis of autism spectrum disorder.

Baranek GT, Woynaroski TG, Nowell S, Turner-Brown L, DuBay M, Crais ER, Watson LR.

Dev Cogn Neurosci. 2018 Jan;29:30-40. doi: 10.1016/j.dcn.2017.08.006. Epub 2017 Aug 14.

11.

Parent-Mediated Intervention for One-Year-Olds Screened as At-Risk for Autism Spectrum Disorder: A Randomized Controlled Trial.

Watson LR, Crais ER, Baranek GT, Turner-Brown L, Sideris J, Wakeford L, Kinard J, Reznick JS, Martin KL, Nowell SW.

J Autism Dev Disord. 2017 Nov;47(11):3520-3540. doi: 10.1007/s10803-017-3268-0.

PMID:
28861651
12.

Risk of hospitalization and death following prostate biopsy in Scotland.

Brewster DH, Fischbacher CM, Nolan J, Nowell S, Redpath D, Nabi G.

Public Health. 2017 Jan;142:102-110. doi: 10.1016/j.puhe.2016.10.006. Epub 2016 Oct 31.

13.

Primary hyperparathyroidism: Increasing prevalence, social deprivation, and surgery.

Collier A, Portelli M, Ghosh S, Nowell S, Clark D.

Endocr Res. 2017 Feb;42(1):31-35. doi: 10.3109/07435800.2016.1169545. Epub 2016 May 2.

PMID:
27135526
14.

Risk of oesophageal cancer among patients previously hospitalised with eating disorder.

Brewster DH, Nowell SL, Clark DN.

Cancer Epidemiol. 2015 Jun;39(3):313-20. doi: 10.1016/j.canep.2015.02.009. Epub 2015 Mar 11.

15.

Association between manganese superoxide dismutase promoter gene polymorphism and breast cancer survival.

Martin RC, Ahn J, Nowell SA, Hein DW, Doll MA, Martini BD, Ambrosone CB.

Breast Cancer Res. 2006;8(4):R45.

16.

Associations between catalase phenotype and genotype: modification by epidemiologic factors.

Ahn J, Nowell S, McCann SE, Yu J, Carter L, Lang NP, Kadlubar FF, Ratnasinghe LD, Ambrosone CB.

Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1217-22.

17.

The role of genetic variability in drug metabolism pathways in breast cancer prognosis.

Choi JY, Nowell SA, Blanco JG, Ambrosone CB.

Pharmacogenomics. 2006 Jun;7(4):613-24. Review.

PMID:
16753008
18.

Pharmacogenetics of human cytosolic sulfotransferases.

Nowell S, Falany CN.

Oncogene. 2006 Mar 13;25(11):1673-8. Review.

PMID:
16550167
19.

Associations between breast cancer risk and the catalase genotype, fruit and vegetable consumption, and supplement use.

Ahn J, Gammon MD, Santella RM, Gaudet MM, Britton JA, Teitelbaum SL, Terry MB, Nowell S, Davis W, Garza C, Neugut AI, Ambrosone CB.

Am J Epidemiol. 2005 Nov 15;162(10):943-52. Epub 2005 Sep 28.

PMID:
16192345
20.

Opposing effects of aspirin and acetaminophen use on risk of adult acute leukemia.

Weiss JR, Baker JA, Baer MR, Menezes RJ, Nowell S, Moysich KB.

Leuk Res. 2006 Feb;30(2):164-9. Epub 2005 Aug 11.

PMID:
16099041
21.

Associations between black tea and coffee consumption and risk of lung cancer among current and former smokers.

Baker JA, McCann SE, Reid ME, Nowell S, Beehler GP, Moysich KB.

Nutr Cancer. 2005;52(1):15-21.

PMID:
16090999
22.

Common genetic polymorphisms in the 5'-flanking region of the SULT1A1 gene: haplotypes and their association with platelet enzymatic activity.

Ning B, Nowell S, Sweeney C, Ambrosone CB, Williams S, Miao X, Liang G, Lin D, Stone A, Ratnasinghe DL, Manjanatha M, Lang NP, Kadlubar FF.

Pharmacogenet Genomics. 2005 Jul;15(7):465-73.

PMID:
15970794
23.

Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients.

Nowell SA, Ahn J, Rae JM, Scheys JO, Trovato A, Sweeney C, MacLeod SL, Kadlubar FF, Ambrosone CB.

Breast Cancer Res Treat. 2005 Jun;91(3):249-58.

25.

Gene-nutrient interactions in cancer etiology.

Nowell SA, Ahn J, Ambrosone CB.

Nutr Rev. 2004 Nov;62(11):427-38. Review.

PMID:
15622715
26.

Examination of human tissue cytosols for expression of sulfotransferase isoform 1A2 (SULT1A2) using a SULT1A2-specific antibody.

Nowell S, Green B, Tang YM, Wiese R, Kadlubar FF.

Mol Pharmacol. 2005 Feb;67(2):394-9. Epub 2004 Nov 4.

PMID:
15528404
27.

Human glutathione S-transferase A2 polymorphisms: variant expression, distribution in prostate cancer cases/controls and a novel form.

Ning B, Wang C, Morel F, Nowell S, Ratnasinghe DL, Carter W, Kadlubar FF, Coles B.

Pharmacogenetics. 2004 Jan;14(1):35-44.

PMID:
15128049
28.

Association of SULT1A1 phenotype and genotype with prostate cancer risk in African-Americans and Caucasians.

Nowell S, Ratnasinghe DL, Ambrosone CB, Williams S, Teague-Ross T, Trimble L, Runnels G, Carrol A, Green B, Stone A, Johnson D, Greene G, Kadlubar FF, Lang NP.

Cancer Epidemiol Biomarkers Prev. 2004 Feb;13(2):270-6.

29.

Effect of dietary constituents with chemopreventive potential on adduct formation of a low dose of the heterocyclic amines PhIP and IQ and phase II hepatic enzymes.

Dingley KH, Ubick EA, Chiarappa-Zucca ML, Nowell S, Abel S, Ebeler SE, Mitchell AE, Burns SA, Steinberg FM, Clifford AJ.

Nutr Cancer. 2003;46(2):212-21.

PMID:
14690798
30.

Novel markers of susceptibility to carcinogens in diet: associations with colorectal cancer.

Sweeney C, Coles BF, Nowell S, Lang NP, Kadlubar FF.

Toxicology. 2002 Dec 27;181-182:83-7.

PMID:
12505289
31.

Association between sulfotransferase 1A1 genotype and survival of breast cancer patients receiving tamoxifen therapy.

Nowell S, Sweeney C, Winters M, Stone A, Lang NP, Hutchins LF, Kadlubar FF, Ambrosone CB.

J Natl Cancer Inst. 2002 Nov 6;94(21):1635-40.

PMID:
12419790
32.

Analysis of total meat intake and exposure to individual heterocyclic amines in a case-control study of colorectal cancer: contribution of metabolic variation to risk.

Nowell S, Coles B, Sinha R, MacLeod S, Luke Ratnasinghe D, Stotts C, Kadlubar FF, Ambrosone CB, Lang NP.

Mutat Res. 2002 Sep 30;506-507:175-85.

PMID:
12351157
33.

CYP2A6 activity determined by caffeine phenotyping: association with colorectal cancer risk.

Nowell S, Sweeney C, Hammons G, Kadlubar FF, Lang NP.

Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):377-83.

35.

Validity of an ELISA for N-acetyltransferase-2 (NAT2) phenotyping.

Wong P, Banerjee K, Massengill J, Nowell S, Lang N, Leyland-Jones B.

J Immunol Methods. 2001 May 1;251(1-2):1-9.

PMID:
11292476
36.

Relationship of phenol sulfotransferase activity (SULT1A1) genotype to sulfotransferase phenotype in platelet cytosol.

Nowell S, Ambrosone CB, Ozawa S, MacLeod SL, Mrackova G, Williams S, Plaxco J, Kadlubar FF, Lang NP.

Pharmacogenetics. 2000 Dec;10(9):789-97.

PMID:
11191883
38.

Cancer therapy and polymorphisms of cytochromes P450.

MacLeod SL, Nowell S, Massengill J, Jazieh A, McClure G, Plaxco J, Kadlubar FF, Lan NP.

Clin Chem Lab Med. 2000 Sep;38(9):883-7. Review.

PMID:
11097344
39.

A simple colorimetric assay for phenotyping the major human thermostable phenol sulfotransferase (SULT1A1) using platelet cytosols.

Frame LT, Ozawa S, Nowell SA, Chou HC, DeLongchamp RR, Doerge DR, Lang NP, Kadlubar FF.

Drug Metab Dispos. 2000 Sep;28(9):1063-8.

PMID:
10950850
40.

In vivo human metabolism of [2-14C]2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).

Lang NP, Nowell S, Malfatti MA, Kulp KS, Knize MG, Davis C, Massengill J, Williams S, MacLeod S, Dingley KH, Felton JS, Turteltaub KW.

Cancer Lett. 1999 Sep 1;143(2):135-8.

PMID:
10503892
41.

Modulation of endocrine pathways by 4,4'-DDE in the deer mouse Peromyscus maniculatus.

Dickerson RL, McMurry CS, Smith EE, Taylor MD, Nowell SA, Frame LT.

Sci Total Environ. 1999 Aug 15;233(1-3):97-108.

PMID:
10492900
42.

DNA and protein adduct formation in the colon and blood of humans after exposure to a dietary-relevant dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.

Dingley KH, Curtis KD, Nowell S, Felton JS, Lang NP, Turteltaub KW.

Cancer Epidemiol Biomarkers Prev. 1999 Jun;8(6):507-12.

43.

Glucuronidation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4, 5-b]pyridine by human microsomal UDP-glucuronosyltransferases: identification of specific UGT1A family isoforms involved.

Nowell SA, Massengill JS, Williams S, Radominska-Pandya A, Tephly TR, Cheng Z, Strassburg CP, Tukey RH, MacLeod SL, Lang NP, Kadlubar FF.

Carcinogenesis. 1999 Jun;20(6):1107-14.

PMID:
10357796
44.

The identification of [2-(14)C]2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine metabolites in humans.

Malfatti MA, Kulp KS, Knize MG, Davis C, Massengill JP, Williams S, Nowell S, MacLeod S, Dingley KH, Turteltaub KW, Lang NP, Felton JS.

Carcinogenesis. 1999 Apr;20(4):705-13.

PMID:
10223203
45.

Identification of enzymes responsible for the metabolism of heme in human platelets.

Nowell SA, Leakey JE, Warren JF, Lang NP, Frame LT.

J Biol Chem. 1998 Dec 11;273(50):33342-6.

46.

Photoaffinity labeling studies of the human recombinant UDP-glucuronosyltransferase, UGT1*6, with 5-azido-UDP-glucuronic acid.

Battaglia E, Nowell S, Drake RR, Magdalou J, Fournel-Gigleux S, Senay C, Radominska A.

Drug Metab Dispos. 1997 Apr;25(4):406-11.

PMID:
9107538
47.
48.

Two kinetically-distinct components of UDP-glucuronic acid transport in rat liver endoplasmic reticulum.

Battaglia E, Nowell S, Drake RR, Mizeracka M, Berg CL, Magdalou J, Fournel-Gigleux S, Gollan JL, Lester R, Radominska A.

Biochim Biophys Acta. 1996 Sep 4;1283(2):223-31.

49.

Photoaffinity labeling of human recombinant sulfotransferases with 2-azidoadenosine 3',5'-[5'-32P]bisphosphate.

Radominska A, Drake RR, Zhu X, Veronese ME, Little JM, Nowell S, McManus ME, Lester R, Falany CN.

J Biol Chem. 1996 Feb 9;271(6):3195-9.

50.

BLIND TRIAL OF A DEGRADED CARRAGEENIN AND ALUMINIUM HYDROXIDE GEL IN THE TREATMENT OF PEPTIC ULCERATION.

EVANS PR, NOWELL S, THOMAS IA.

Postgrad Med J. 1965 Jan;41:48-52. No abstract available.

Supplemental Content

Loading ...
Support Center